NCT02454426View on ClinicalTrials.gov

Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Major Depressive DisorderCoronary Artery Disease
Interventions
DRUG

Vortioxetine

open label treatment

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Thomas Jefferson University

OTHER